Your shopping cart is empty!
PDF Preview
Clinical and Laboratory Standards Institute, 06/21/2022
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:21/06/2022
Pages:104
File Size:1 file , 6.8 MB
Note:This product is unavailable in Russia, Belarus
This document provides guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays. This guideline emphasizes particular areas related to assay development and presents a standardized approach for method verification that is specific to mass spectrometry technology.
Nongynecologic Cytologic Specimens: Preexamination, Examination, and Postexamination Processes; Approved Guideline - Second Edition, , GP23A2E
$101.00 $202.00
Liquid Chromatography-Mass Spectrometry Methods; Approved Guideline, C62AE
$90.00 $180.00
Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Approved Guideline , VET03AE; Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second Informational Supplement, VET03VET04S2E
IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard, AUTO11A2E
